Tectonic Therapeutic Book Value Per Share Growth & History (TECX)
Tectonic Therapeutic's book value per share was $13.41 for fiscal 2025.
View full Tectonic Therapeutic company overviewTectonic Therapeutic annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.41 | $3.94 | +41.55% |
| 2024 | 2024-12-31 | $9.48 | $69.60 | — |
| 2023 | 2023-12-31 | -$60.12 | -$26.78 | — |
| 2022 | 2022-12-31 | -$33.34 | -$157.88 | — |
| 2021 | 2021-12-31 | $124.53 | -$62.36 | −33.37% |
| 2020 | 2020-12-31 | $186.89 | -$1.66 | −0.88% |
| 2019 | 2019-12-31 | $188.56 | $23.93 | +14.54% |
| 2018 | 2018-12-31 | $164.62 | $486.54 | — |
| 2017 | 2017-12-31 | -$321.91 | — | — |
Tectonic Therapeutic quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.64 | -$3.53 | −23.26% |
| Q1 2026 | 2026-03-31 | $12.24 | -$3.89 | −24.11% |
| Q4 2025 | 2025-12-31 | $13.41 | $3.94 | +41.55% |
| Q3 2025 | 2025-09-30 | $14.30 | $4.10 | +40.19% |
| Q2 2025 | 2025-06-30 | $15.16 | $3.87 | +34.31% |
| Q1 2025 | 2025-03-31 | $16.12 | $87.28 | — |
| Q4 2024 | 2024-12-31 | $9.48 | $69.60 | — |
| Q3 2024 | 2024-09-30 | $10.20 | $67.63 | — |
| Q2 2024 | 2024-06-30 | $11.29 | $61.97 | — |
| Q1 2024 | 2024-03-31 | -$71.16 | -$27.64 | — |
| Q4 2023 | 2023-12-31 | -$60.12 | -$26.78 | — |
| Q3 2023 | 2023-09-30 | -$57.43 | -$129.31 | — |
| Q2 2023 | 2023-06-30 | -$50.68 | -$137.55 | — |
| Q1 2023 | 2023-03-31 | -$43.52 | -$148.61 | — |
| Q4 2022 | 2022-12-31 | -$33.34 | -$157.88 | — |
| Q3 2022 | 2022-09-30 | $71.88 | -$70.42 | −49.49% |
| Q2 2022 | 2022-06-30 | $86.87 | -$75.62 | −46.54% |
| Q1 2022 | 2022-03-31 | $105.09 | -$73.80 | −41.25% |
| Q4 2021 | 2021-12-31 | $124.53 | -$62.36 | −33.37% |
| Q3 2021 | 2021-09-30 | $142.30 | -$40.63 | −22.21% |
| Q2 2021 | 2021-06-30 | $162.49 | -$48.62 | −23.03% |
| Q1 2021 | 2021-03-31 | $178.89 | -$49.60 | −21.71% |
| Q4 2020 | 2020-12-31 | $186.89 | -$1.66 | −0.88% |
| Q3 2020 | 2020-09-30 | $182.93 | -$26.90 | −12.82% |
| Q2 2020 | 2020-06-30 | $211.11 | $87.80 | +71.20% |
| Q1 2020 | 2020-03-31 | $228.49 | $85.50 | +59.79% |
| Q4 2019 | 2019-12-31 | $188.56 | $23.93 | +14.54% |
| Q3 2019 | 2019-09-30 | $209.83 | $24.72 | +13.36% |
| Q2 2019 | 2019-06-30 | $123.31 | -$77.23 | −38.51% |
| Q1 2019 | 2019-03-31 | $142.99 | — | — |
| Q4 2018 | 2018-12-31 | $164.62 | $486.54 | — |
| Q3 2018 | 2018-09-30 | $185.10 | — | — |
| Q2 2018 | 2018-06-30 | $200.55 | — | — |
| Q4 2017 | 2017-12-31 | -$321.91 | — | — |
Tectonic Therapeutic book value per share trends
Over the last five fiscal years, Tectonic Therapeutic's book value per share decreased from $186.89 to $13.41, a change of -$173.48. The latest reported quarter, Q2 2026, shows $11.64.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tectonic Therapeutic source filings ↗